Status: Recruiting
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Participants needed: 80
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Angitia Incorporated LimitedUpdated: Aug 17, 2026Locations: 26
Eligibility criteria
Male or female adults (aged 18 to 75 years inclusive) with a clinical diagnosis... [+2]
Vitamin D deficiency [+11]